JR Pharma Engineering Holding ApS: Financial statements 2024
CVR: 42396273
Source: annual report 2024, Danish Business Authority
01/07/2023 – 30/06/2024
JR Pharma Engineering Holding ApS (CVR 42396273) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 0 and a net result of DKK 649,533 compared with DKK 1,200,461 the year before. Equity in the 2024 report amounted to DKK 1,849,994. The solvency ratio was 100%.
- Revenue
- DKK 0
- Gross Profit
- DKK 0
- Profit/Loss
- DKK 649,533
- Equity
- DKK 1,849,994
- Total Assets
- DKK 1,849,994
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | 0 | 0 | 650 t. | 1.8 mio. | - |
| 2023 | 0 | 0 | 1.2 mio. | 1.2 mio. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningAbout JR Pharma Engineering Holding ApS
JR Pharma Engineering Holding ApS is a Danish company of the type Anpartsselskab based in Charlottenlund, founded in 2021. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Jimmy Rønne Jensen. The company is owned by Jimmy Rønne Jensen. According to the 2026 annual report, the company had an average of 0 employees. In 2026, the company reported a gross profit of DKK 554,386 and a net result of DKK 560,509 compared with DKK 601,978 the year before. Equity in the 2026 report amounted to DKK 3,012,480.